Siwen Wang
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Mechanisms and Therapeutic Targeting of the Gut Microbiota-Immune-Brain Axis in Alzheimer's Disease.
Mechanisms and Therapeutic Targeting of the Gut Microbiota-Immune-Brain Axis in Alzheimer's Disease.
Journal: Immunological investigations
Published: May 11, 2026
Retraction Note: Effect of Danhong injection on pharmacokinetics and pharmacodynamics of rivaroxaban in rats.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: August 14, 2025
Combined Analysis of Network Toxicology and Multiomics Revealed the Potential Mechanism of 6PPDQ-Induced Hepatotoxicity in Mice.
Journal: Environmental science & technology
Published: May 19, 2025
Regulatory effect of atorvastatin combined with berberine on PI3K/AKT/FoxO1 signaling pathway in rats with hyperlipidaemia.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: May 12, 2025
Effect of Curcuminoids on Pharmacokinetics and Pharmacodynamics of Atorvastatin in Hyperlipidemia Rats and Its Potential Mechanism.
Journal: Biopharmaceutics & drug disposition
Published: December 01, 2024
Effect of Danhong injection on pharmacokinetics and pharmacodynamics of rivaroxaban in rats.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 22, 2024
Gut microbiota: a potential influencer of insomnia occurring after COVID-19 infection.
Journal: Frontiers in psychiatry
Published: April 26, 2024
Effect of berberine on pharmacokinetics and pharmacodynamics of atorvastatin in hyperlipidemia rats.
Effect of berberine on pharmacokinetics and pharmacodynamics of atorvastatin in hyperlipidemia rats.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: December 06, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026